Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $161.70 million. The enterprise value is $81.70 million.
Important Dates
The next confirmed earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 51.33 million shares outstanding. The number of shares has increased by 3.10% in one year.
| Current Share Class | 51.33M |
| Shares Outstanding | 51.33M |
| Shares Change (YoY) | +3.10% |
| Shares Change (QoQ) | +0.91% |
| Owned by Insiders (%) | 20.22% |
| Owned by Institutions (%) | 36.26% |
| Float | 31.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.98 |
| Forward PS | 2.04 |
| PB Ratio | 1.83 |
| P/TBV Ratio | 1.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.04, with a Debt / Equity ratio of 0.46.
| Current Ratio | 9.04 |
| Quick Ratio | 8.48 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.84 |
Financial Efficiency
Return on equity (ROE) is -49.59% and return on invested capital (ROIC) is -22.28%.
| Return on Equity (ROE) | -49.59% |
| Return on Assets (ROA) | -20.41% |
| Return on Invested Capital (ROIC) | -22.28% |
| Return on Capital Employed (ROCE) | -39.67% |
| Revenue Per Employee | $369,750 |
| Profits Per Employee | -$238,458 |
| Employee Count | 216 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.63 |
Taxes
In the past 12 months, Sight Sciences has paid $236,000 in taxes.
| Income Tax | 236,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.10% in the last 52 weeks. The beta is 2.45, so Sight Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.45 |
| 52-Week Price Change | -41.10% |
| 50-Day Moving Average | 2.64 |
| 200-Day Moving Average | 4.46 |
| Relative Strength Index (RSI) | 63.38 |
| Average Volume (20 Days) | 199,553 |
Short Selling Information
The latest short interest is 1.48 million, so 2.89% of the outstanding shares have been sold short.
| Short Interest | 1.48M |
| Short Previous Month | 1.71M |
| Short % of Shares Out | 2.89% |
| Short % of Float | 4.70% |
| Short Ratio (days to cover) | 7.58 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $79.87 million and -$51.51 million in losses. Loss per share was -$1.03.
| Revenue | 79.87M |
| Gross Profit | 68.29M |
| Operating Income | -50.53M |
| Pretax Income | -52.20M |
| Net Income | -51.51M |
| EBITDA | -49.82M |
| EBIT | -50.53M |
| Loss Per Share | -$1.03 |
Full Income StatementBalance Sheet
The company has $120.36 million in cash and $40.36 million in debt, giving a net cash position of $80.00 million or $1.56 per share.
| Cash & Cash Equivalents | 120.36M |
| Total Debt | 40.36M |
| Net Cash | 80.00M |
| Net Cash Per Share | $1.56 |
| Equity (Book Value) | 87.52M |
| Book Value Per Share | 1.72 |
| Working Capital | 124.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$22.35 million and capital expenditures -$385,000, giving a free cash flow of -$22.74 million.
| Operating Cash Flow | -22.35M |
| Capital Expenditures | -385,000 |
| Free Cash Flow | -22.74M |
| FCF Per Share | -$0.44 |
Full Cash Flow StatementMargins
Gross margin is 85.50%, with operating and profit margins of -63.27% and -64.49%.
| Gross Margin | 85.50% |
| Operating Margin | -63.27% |
| Pretax Margin | -64.20% |
| Profit Margin | -64.49% |
| EBITDA Margin | -62.38% |
| EBIT Margin | -63.27% |
| FCF Margin | n/a |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.10% |
| Shareholder Yield | -3.10% |
| Earnings Yield | -31.85% |
| FCF Yield | -14.06% |
Analyst Forecast
The average price target for Sight Sciences is $3.83, which is 23.15% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.83 |
| Price Target Difference | 23.15% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of 0.01 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.01 |
| Piotroski F-Score | 3 |